• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
Search 
  •   DSpace@İSÜ
  • Search
  •   DSpace@İSÜ
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-3 of 3

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100

Lower prognostic nutritional index is associated with poorer survival in patients receiving ımmune-checkpoint ınhibitors 

Guven, Deniz C.; Aktepe, Oktay H.; Taban, Hakan; Aktas, Burak Y.; Guner, Gurkan; Yildirim, Hasan C.; Kilickap, Saadettin (Future Medicine, 2021)
Aim: Blood-based biomarkers like prognostic nutritional index (PNI) are readily available biomarkers for immunotherapy efficacy, although the data are limited. So, we aimed to evaluate the association between PNI and overall ...

Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database 

Yekeduz, Emre; Erturk, Ismail; Tural, Deniz; Karadurmus, Nuri; Karakaya, Serdar; Kilickap, Saadettin (Future Medicine, 2021)
Aim: The authors present real-world data on the efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC). Methods: The Turkish Oncology Group Kidney Cancer Consortium (TKCC) database includes ...

The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors 

Guven, Deniz Can; Aktepe, Oktay Halit; Aksun, Melek Seren; Sahin , Taha Koray; Kavgaci, Gozde; Ucgul, Enes; Cakir, Ibrahim Yahya; Yildirim, Hasan Cagri; Guner, Gurkan; Akin, Serkan; Kertmen, Neyran; Dizdar, Omer; Aksoy, Sercan; Erman, Mustafa; Suayib, Yalcin; Kilickap, Saadettin (IOS Press, 2022)
BACKGROUND: The albumin-globulin ratio (AGR) could be a prognostic biomarker in patients with cancer, although the data is limited in patients treated with immune-checkpoint inhibitors (ICIs). OBJECTIVES: We aimed to ...



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution Author

My Account

LoginRegister

Discover

AuthorKilickap, Saadettin (3)Guner, Gurkan (2)Akin, Serkan (1)Aksoy, Sercan (1)Aksun, Melek Seren (1)Aktas, Burak Y. (1)Aktepe, Oktay H. (1)Aktepe, Oktay Halit (1)Cakir, Ibrahim Yahya (1)Dizdar, Omer (1)... View MoreSubject
Immunotherapy (3)
Albumin-Globulin Ratio (1)Biomarker (1)Biomarkers (1)ECOG (1)Immune Checkpoint Inhibitor (1)Kidney Cancer (1)LDH (1)Nivolumab (1)Prognostic Nutritional Index (1)... View MoreDate Issued2021 (2)2022 (1)Full Text Status
Without Full Text (3)

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide|| Instruction || Library || İstinye University || OAI-PMH ||

İstinye University, İstanbul, Turkey
If you find any errors in content, please contact:

Creative Commons License
İstinye University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@İSÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.